When the Going Gets Tough: Treating Chronic Idiopathic Constipation – Clinical Forum

Thumbnail

Activity Overview

The goal of this activity is to explore the pathophysiology of chronic idiopathic constipation (CIC), discuss key data on prescription CIC therapies, and debate crucial questions in the development and personalization of treatment plans for patients with CIC.

1.00 CE Credit(s)
Expires: September 30, 2021

Target Audience

This activity was developed for physicians and other healthcare professionals treating patients with chronic idiopathic constipation (CIC).

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Describe the underlying pathophysiology of chronic idiopathic constipation (CIC)
  • Apply key data on the benefits and risks of available therapies for the treatment of CIC
  • Develop evidence-based treatment plans with clear goals and coordinated care for individuals with CIC

Activity Faculty

Cash

Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE (Chair)

Dan and Lillie Sterling Professor of Gastroenterology
Chief, Gastroenterology, Hepatology, and Nutrition Division
Director, Gastrointestinal Physiology Laboratory
Memorial Hermann Hospital, Texas Medical Center
University of Texas Health Science Center at Houston
McGovern Medical School
Houston, TX

Darren2

Darren M. Brenner, MD, FACG, AGAF

Associate Professor, Medicine and Surgery
Irene D. Pritzker Foundation Research Scholar
Director, Northwestern Neurogastromotility and Functional Bowel Programs
Director, Motts Tonelli GI Physiology Laboratory
Northwestern University – Feinberg School of Medicine
Chicago, IL

Harris

Lucinda A. Harris, MS, MD

Associate Professor, Medicine
Consultant, Division of Gastroenterology & Hepatology
Department of Medicine
Mayo Clinic
Scottsdale, AZ